SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Exelixis, Inc. – ‘10-Q’ for 9/29/23 – ‘EX-101.CAL’

On:  Wednesday, 11/1/23, at 4:16pm ET   ·   For:  9/29/23   ·   Accession #:  939767-23-114   ·   File #:  0-30235

Previous ‘10-Q’:  ‘10-Q’ on 8/1/23 for 6/30/23   ·   Next & Latest:  ‘10-Q’ on 4/30/24 for 3/29/24   ·   3 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

11/01/23  Exelixis, Inc.                    10-Q        9/29/23   73:6.8M

Quarterly Report   —   Form 10-Q

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML   1.28M 
 2: EX-10.1     Material Contract                                   HTML     45K 
 3: EX-10.2     Material Contract                                   HTML    140K 
 4: EX-10.3     Material Contract                                   HTML     24K 
 5: EX-31.1     Certification -- §302 - SOA'02                      HTML     26K 
 6: EX-31.2     Certification -- §302 - SOA'02                      HTML     26K 
 7: EX-32.1     Certification -- §906 - SOA'02                      HTML     24K 
13: R1          Cover Page                                          HTML     74K 
14: R2          Condensed Consolidated Balance Sheets               HTML    127K 
15: R3          Condensed Consolidated Balance Sheets               HTML     41K 
                (Parenthetical)                                                  
16: R4          Condensed Consolidated Statements of Income         HTML     92K 
17: R5          Condensed Consolidated Statements of Comprehensive  HTML     43K 
                Income                                                           
18: R6          Condensed Consolidated Statements of Comprehensive  HTML     25K 
                Income (Parenthetical)                                           
19: R7          Condensed Consolidated Statements of Stockholders'  HTML     84K 
                Equity                                                           
20: R8          Condensed Consolidated Statements of Cash Flows     HTML     95K 
21: R9          Organization and Summary of Significant Accounting  HTML     36K 
                Policies                                                         
22: R10         Revenues                                            HTML    126K 
23: R11         Collaboration Agreements And Business Development   HTML     57K 
                Activities                                                       
24: R12         Cash and Investments                                HTML     93K 
25: R13         Fair Value Measurements                             HTML     59K 
26: R14         Inventory                                           HTML     34K 
27: R15         Stockholders? Equity                                HTML     61K 
28: R16         Provision For Income Taxes                          HTML     27K 
29: R17         Net Income Per Share                                HTML     49K 
30: R18         Commitments and Contingencies                       HTML     42K 
31: R19         Pay vs Performance Disclosure                       HTML     34K 
32: R20         Insider Trading Arrangements                        HTML     41K 
33: R21         Organization and Summary of Significant Accounting  HTML     53K 
                Policies (Policies)                                              
34: R22         Revenues (Tables)                                   HTML    126K 
35: R23         Collaboration Agreements And Business Development   HTML     46K 
                Activities (Tables)                                              
36: R24         Cash and Investments (Tables)                       HTML     93K 
37: R25         Fair Value Measurements (Tables)                    HTML     54K 
38: R26         Inventory (Tables)                                  HTML     35K 
39: R27         Stockholders? Equity (Tables)                       HTML     54K 
40: R28         Net Income Per Share (Tables)                       HTML     50K 
41: R29         Organization and Summary of Significant Accounting  HTML     30K 
                Policies (Details)                                               
42: R30         Revenues - Revenues by Disaggregated Category       HTML     43K 
                (Details)                                                        
43: R31         Revenues - Revenues Disaggregated by Concentration  HTML     50K 
                Risks (Details)                                                  
44: R32         Revenues - Revenues Disaggregated by Geographic     HTML     36K 
                Region (Details)                                                 
45: R33         Revenues - Net Product Revenues Disaggregated by    HTML     36K 
                Product (Details)                                                
46: R34         Revenues - Activities and Ending Reserve Balances   HTML     43K 
                for Significant Categories of Discounts and                      
                Allowances (Details)                                             
47: R35         Revenues - Contract Assets and Liabilities          HTML     41K 
                (Details)                                                        
48: R36         Collaboration Agreements And Business Development   HTML     38K 
                Activities - Collaboration Revenues under the                    
                Collaboration Agreement with Ipsen (Details)                     
49: R37         Collaboration Agreements And Business Development   HTML     26K 
                Activities - Ipsen Collaboration Narrative                       
                (Details)                                                        
50: R38         Collaboration Agreements And Business Development   HTML     38K 
                Activities - Collaboration Revenues under the                    
                Collaboration Agreement with Takeda (Details)                    
51: R39         Collaboration Agreements And Business Development   HTML     34K 
                Activities - Takeda Collaboration Narrative                      
                (Details)                                                        
52: R40         Collaboration Agreements And Business Development   HTML     30K 
                Activities -Royalty Pharma Narrative (Details)                   
53: R41         Collaboration Agreements And Business Development   HTML     40K 
                Activities - Research Collaborations and                         
                In-Licensing Arrangements Narrative (Details)                    
54: R42         Cash and Investments - Investments by Security      HTML     71K 
                Type (Details)                                                   
55: R43         Cash and Investments - Narrative (Details)          HTML     49K 
56: R44         Cash and Investments - Fair Value and Gross         HTML     35K 
                Unrealized Losses of Investments                                 
                Available-for-Sale in an Unrealized Loss Position                
                (Details)                                                        
57: R45         Cash and Investments - Fair Value of Cash           HTML     30K 
                Equivalents and Investments by Contractual                       
                Maturity (Details)                                               
58: R46         Fair Value Measurements (Fair Value Hierarchy)      HTML     69K 
                (Details)                                                        
59: R47         Fair Value Measurements - Narratives (Details)      HTML     34K 
60: R48         Inventory (Details)                                 HTML     34K 
61: R49         Stockholders' Equity - Narrative (Details)          HTML    108K 
62: R50         Stockholders? Equity - Schedule of Allocated        HTML     30K 
                Employee Stock-Based Compensation Expense                        
                (Details)                                                        
63: R51         Stockholders? Equity - Schedule of Employee         HTML     42K 
                Service Share - Based Compensation Expense                       
                (Details)                                                        
64: R52         Stockholders? Equity - Estimate Grant-Date Fair     HTML     42K 
                Value (Details)                                                  
65: R53         Provision For Income Taxes (Details)                HTML     24K 
66: R54         Net Income Per Share - Computation of Basic and     HTML     56K 
                Diluted Net Income Per Share (Details)                           
67: R55         Net Income Per Share - Potential Shares of Common   HTML     27K 
                Stock Not Included in the Computation of Diluted                 
                Net Income Per Share (Details)                                   
68: R56         Commitments and Contingencies (Details)             HTML     29K 
71: XML         IDEA XML File -- Filing Summary                      XML    128K 
69: XML         XBRL Instance -- exel-20230929_htm                   XML   1.56M 
70: EXCEL       IDEA Workbook of Financial Report Info              XLSX    122K 
 9: EX-101.CAL  XBRL Calculations -- exel-20230929_cal               XML    154K 
10: EX-101.DEF  XBRL Definitions -- exel-20230929_def                XML    479K 
11: EX-101.LAB  XBRL Labels -- exel-20230929_lab                     XML   1.44M 
12: EX-101.PRE  XBRL Presentations -- exel-20230929_pre              XML    853K 
 8: EX-101.SCH  XBRL Schema -- exel-20230929                         XSD    138K 
72: JSON        XBRL Instance as JSON Data -- MetaLinks              417±   613K 
73: ZIP         XBRL Zipped Folder -- 0000939767-23-000114-xbrl      Zip    395K 


‘EX-101.CAL’   —   XBRL Calculations — exel-20230929_cal


This Exhibit is an XBRL File.


                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<!-- XBRL Document Created with the Workiva Platform -->
<!-- Copyright 2023 Workiva -->
<!-- r:17ff0099-c059-48d9-93f6-9998a3d60bae,g:4f0bc724-9d2b-4b03-8e50-a18dd0be52a9 -->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:roleRef roleURI="http://www.exelixis.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="exel-20230929.xsd#CondensedConsolidatedBalanceSheets"/>
<link:calculationLink xlink:role="http://www.exelixis.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_b457c57a-f09c-4adc-8bc4-0746b21e93e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_f6fab34c-e416-4347-83a6-6d4a630eb287" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_b457c57a-f09c-4adc-8bc4-0746b21e93e2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_f6fab34c-e416-4347-83a6-6d4a630eb287" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_exel_OperatingLeaseRightOfUseAssetAndOtherAssets_e0a18df8-a0f7-42e1-bc38-cc5353037b70" xlink:href="exel-20230929.xsd#exel_OperatingLeaseRightOfUseAssetAndOtherAssets"/>
<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_b457c57a-f09c-4adc-8bc4-0746b21e93e2" xlink:to="loc_exel_OperatingLeaseRightOfUseAssetAndOtherAssets_e0a18df8-a0f7-42e1-bc38-cc5353037b70" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_0f4c4b4b-3ce4-4483-bc6f-32b1f63d65a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
<link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_b457c57a-f09c-4adc-8bc4-0746b21e93e2" xlink:to="loc_us-gaap_Goodwill_0f4c4b4b-3ce4-4483-bc6f-32b1f63d65a3" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_8a1d134d-2158-49d6-a7d6-14cf60b24597" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermInvestments"/>
<link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_b457c57a-f09c-4adc-8bc4-0746b21e93e2" xlink:to="loc_us-gaap_LongTermInvestments_8a1d134d-2158-49d6-a7d6-14cf60b24597" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_104ca2a8-447e-4e02-a480-fd71943d879a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
<link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_b457c57a-f09c-4adc-8bc4-0746b21e93e2" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_104ca2a8-447e-4e02-a480-fd71943d879a" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_756f312e-0b27-4dce-a2de-2dae58403c62" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
<link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_b457c57a-f09c-4adc-8bc4-0746b21e93e2" xlink:to="loc_us-gaap_AssetsCurrent_756f312e-0b27-4dce-a2de-2dae58403c62" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_98a19a1b-3aa2-4046-a322-1d4fea552fd3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_0766a556-6834-4110-aa69-91c202cefe3c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_98a19a1b-3aa2-4046-a322-1d4fea552fd3" xlink:to="loc_us-gaap_Liabilities_0766a556-6834-4110-aa69-91c202cefe3c" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_e5239517-4783-4019-b70e-e2e4de9089db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_98a19a1b-3aa2-4046-a322-1d4fea552fd3" xlink:to="loc_us-gaap_CommitmentsAndContingencies_e5239517-4783-4019-b70e-e2e4de9089db" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_66b4db49-cd88-436c-a732-4b8872046a37" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
<link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_98a19a1b-3aa2-4046-a322-1d4fea552fd3" xlink:to="loc_us-gaap_StockholdersEquity_66b4db49-cd88-436c-a732-4b8872046a37" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_b8085db7-3c63-4ed9-8c57-036a2b90ed09" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_2abea6ab-56c9-4251-b848-3de06865b8ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent"/>
<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_b8085db7-3c63-4ed9-8c57-036a2b90ed09" xlink:to="loc_us-gaap_AccountsPayableCurrent_2abea6ab-56c9-4251-b848-3de06865b8ed" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedEmployeeBenefitsCurrent_dabfd882-20de-4531-88f0-8daba60f6d11" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedEmployeeBenefitsCurrent"/>
<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_b8085db7-3c63-4ed9-8c57-036a2b90ed09" xlink:to="loc_us-gaap_AccruedEmployeeBenefitsCurrent_dabfd882-20de-4531-88f0-8daba60f6d11" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_exel_AccruedClinicalLiabilitiesCurrent_643311a1-88b4-4d85-93bf-ff623fa25c26" xlink:href="exel-20230929.xsd#exel_AccruedClinicalLiabilitiesCurrent"/>
<link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_b8085db7-3c63-4ed9-8c57-036a2b90ed09" xlink:to="loc_exel_AccruedClinicalLiabilitiesCurrent_643311a1-88b4-4d85-93bf-ff623fa25c26" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRefundLiabilityCurrent_8108e7f1-934c-407e-bcb6-eb82497c17fc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerRefundLiabilityCurrent"/>
<link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_b8085db7-3c63-4ed9-8c57-036a2b90ed09" xlink:to="loc_us-gaap_CustomerRefundLiabilityCurrent_8108e7f1-934c-407e-bcb6-eb82497c17fc" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_exel_AccruedCollaborationLiabilityCurrent_bdcfc52e-9716-46d4-83d7-ab0cb1b6ce1a" xlink:href="exel-20230929.xsd#exel_AccruedCollaborationLiabilityCurrent"/>
<link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_b8085db7-3c63-4ed9-8c57-036a2b90ed09" xlink:to="loc_exel_AccruedCollaborationLiabilityCurrent_bdcfc52e-9716-46d4-83d7-ab0cb1b6ce1a" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_e88c88b5-56db-4514-871a-9f861c62f876" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
<link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_b8085db7-3c63-4ed9-8c57-036a2b90ed09" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_e88c88b5-56db-4514-871a-9f861c62f876" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_8f128402-818c-4c07-9697-c34f243d6b44" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_46498b36-4f7c-45fc-a07d-85cb992cdfde" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermInvestments"/>
<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_8f128402-818c-4c07-9697-c34f243d6b44" xlink:to="loc_us-gaap_ShortTermInvestments_46498b36-4f7c-45fc-a07d-85cb992cdfde" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_c6ad2cec-6250-44c3-86a8-b45d52abe94b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivablesNetCurrent"/>
<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_8f128402-818c-4c07-9697-c34f243d6b44" xlink:to="loc_us-gaap_ReceivablesNetCurrent_c6ad2cec-6250-44c3-86a8-b45d52abe94b" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_a5c3b228-f410-4b42-a724-fa4811525105" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
<link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_8f128402-818c-4c07-9697-c34f243d6b44" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_a5c3b228-f410-4b42-a724-fa4811525105" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_b94775e8-43f7-4f8e-81a0-9fef030fda5b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
<link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_8f128402-818c-4c07-9697-c34f243d6b44" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_b94775e8-43f7-4f8e-81a0-9fef030fda5b" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_68501153-0f29-44a9-b306-3e0852403f93" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet"/>
<link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_8f128402-818c-4c07-9697-c34f243d6b44" xlink:to="loc_us-gaap_InventoryNet_68501153-0f29-44a9-b306-3e0852403f93" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_d131fdb7-2237-45fb-90a1-13d9550bf50e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_07c0c49a-34b4-4ecd-8460-379d557a4e79" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_d131fdb7-2237-45fb-90a1-13d9550bf50e" xlink:to="loc_us-gaap_LiabilitiesCurrent_07c0c49a-34b4-4ecd-8460-379d557a4e79" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_464fbc91-fb43-4411-893a-4a86b0baf0c2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_d131fdb7-2237-45fb-90a1-13d9550bf50e" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_464fbc91-fb43-4411-893a-4a86b0baf0c2" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_1d15cab0-0142-4886-adac-851e7f5ec11b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
<link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_d131fdb7-2237-45fb-90a1-13d9550bf50e" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_1d15cab0-0142-4886-adac-851e7f5ec11b" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_987b618b-b6d4-47e3-b042-8ab963fa486b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_14a7bf18-67cb-4686-94d2-b3e5b35fbcc6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue"/>
<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_987b618b-b6d4-47e3-b042-8ab963fa486b" xlink:to="loc_us-gaap_PreferredStockValue_14a7bf18-67cb-4686-94d2-b3e5b35fbcc6" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_5b16bb07-9358-4f50-bd18-dda4d8eb739c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_987b618b-b6d4-47e3-b042-8ab963fa486b" xlink:to="loc_us-gaap_CommonStockValue_5b16bb07-9358-4f50-bd18-dda4d8eb739c" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_4afeaf10-f7ec-4f1d-87e7-822314818252" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital"/>
<link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_987b618b-b6d4-47e3-b042-8ab963fa486b" xlink:to="loc_us-gaap_AdditionalPaidInCapital_4afeaf10-f7ec-4f1d-87e7-822314818252" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_d8be2e32-983a-42c2-bb8f-df122f50c988" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
<link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_987b618b-b6d4-47e3-b042-8ab963fa486b" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_d8be2e32-983a-42c2-bb8f-df122f50c988" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_fb0ba304-10d8-4a25-94c6-9cb1fc6d105a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
<link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_987b618b-b6d4-47e3-b042-8ab963fa486b" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_fb0ba304-10d8-4a25-94c6-9cb1fc6d105a" xlink:type="arc"/>
</link:calculationLink>
<link:roleRef roleURI="http://www.exelixis.com/role/CondensedConsolidatedStatementsofIncome" xlink:type="simple" xlink:href="exel-20230929.xsd#CondensedConsolidatedStatementsofIncome"/>
<link:calculationLink xlink:role="http://www.exelixis.com/role/CondensedConsolidatedStatementsofIncome" xlink:type="extended">
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_327b477b-5f03-4210-b7be-3c8f4bea4952" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_4902b1cb-ba2e-4313-aac5-b962ea956ab6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostsAndExpenses"/>
<link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_327b477b-5f03-4210-b7be-3c8f4bea4952" xlink:to="loc_us-gaap_CostsAndExpenses_4902b1cb-ba2e-4313-aac5-b962ea956ab6" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c8ddf7f0-b43f-4e67-8b83-50912514696c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_327b477b-5f03-4210-b7be-3c8f4bea4952" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c8ddf7f0-b43f-4e67-8b83-50912514696c" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_38bb8f04-56ad-45e5-9019-897f1c07b382" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostsAndExpenses"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_466d3fc1-dc76-41a3-b61b-669f99443bbb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_38bb8f04-56ad-45e5-9019-897f1c07b382" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_466d3fc1-dc76-41a3-b61b-669f99443bbb" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_f7472001-70a4-4f5a-86bc-4f8463b83061" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_38bb8f04-56ad-45e5-9019-897f1c07b382" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_f7472001-70a4-4f5a-86bc-4f8463b83061" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_93f3cf29-c03d-4771-a5da-73ff201d3481" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
<link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_38bb8f04-56ad-45e5-9019-897f1c07b382" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_93f3cf29-c03d-4771-a5da-73ff201d3481" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_0c919465-9314-4317-9a0b-b89632b97523" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossAttributableToParent_af4aa9a6-0836-4320-bf92-e464f0c8cf90" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossAttributableToParent"/>
<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_0c919465-9314-4317-9a0b-b89632b97523" xlink:to="loc_us-gaap_IncomeLossAttributableToParent_af4aa9a6-0836-4320-bf92-e464f0c8cf90" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_af926ad9-151f-4ff1-9907-36317bee45f8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
<link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_0c919465-9314-4317-9a0b-b89632b97523" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_af926ad9-151f-4ff1-9907-36317bee45f8" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossAttributableToParent_7a39004e-845c-4797-a135-b50943553f65" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossAttributableToParent"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_bb5c8cf7-e25e-4689-b30f-f6d93ee86589" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossAttributableToParent_7a39004e-845c-4797-a135-b50943553f65" xlink:to="loc_us-gaap_OperatingIncomeLoss_bb5c8cf7-e25e-4689-b30f-f6d93ee86589" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeOther_cc48ea2b-fb47-46b2-8ae4-ec99d9d83bed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeOther"/>
<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossAttributableToParent_7a39004e-845c-4797-a135-b50943553f65" xlink:to="loc_us-gaap_InterestIncomeOther_cc48ea2b-fb47-46b2-8ae4-ec99d9d83bed" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_37711e5a-04b1-4fab-9901-79f495786097" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
<link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossAttributableToParent_7a39004e-845c-4797-a135-b50943553f65" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_37711e5a-04b1-4fab-9901-79f495786097" xlink:type="arc"/>
</link:calculationLink>
<link:roleRef roleURI="http://www.exelixis.com/role/CondensedConsolidatedStatementsofComprehensiveIncome" xlink:type="simple" xlink:href="exel-20230929.xsd#CondensedConsolidatedStatementsofComprehensiveIncome"/>
<link:calculationLink xlink:role="http://www.exelixis.com/role/CondensedConsolidatedStatementsofComprehensiveIncome" xlink:type="extended">
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_28d02c62-129f-4f41-9fe5-13deac7b47c1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c19705e6-28be-4934-bb70-1b8ce0fd62c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_28d02c62-129f-4f41-9fe5-13deac7b47c1" xlink:to="loc_us-gaap_NetIncomeLoss_c19705e6-28be-4934-bb70-1b8ce0fd62c5" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_d4d6954f-7734-4357-be49-a34f3dcacd32" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_28d02c62-129f-4f41-9fe5-13deac7b47c1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_d4d6954f-7734-4357-be49-a34f3dcacd32" xlink:type="arc"/>
</link:calculationLink>
<link:roleRef roleURI="http://www.exelixis.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="exel-20230929.xsd#CondensedConsolidatedStatementsofCashFlows"/>
<link:calculationLink xlink:role="http://www.exelixis.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_79ff24cb-e177-48ce-a334-1292101751b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0fb295ba-0b60-4d63-85b3-3640ed0c856b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
<link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_79ff24cb-e177-48ce-a334-1292101751b7" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0fb295ba-0b60-4d63-85b3-3640ed0c856b" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_fab38674-8e0e-4b03-957a-56fe420f67cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireInvestments"/>
<link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_79ff24cb-e177-48ce-a334-1292101751b7" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_fab38674-8e0e-4b03-957a-56fe420f67cc" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_d9fe29e4-2f60-41d7-80ed-b8f331276e86" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments"/>
<link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_79ff24cb-e177-48ce-a334-1292101751b7" xlink:to="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_d9fe29e4-2f60-41d7-80ed-b8f331276e86" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment_088ea5cd-802a-4058-91bf-71dc46a6a68f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment"/>
<link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_79ff24cb-e177-48ce-a334-1292101751b7" xlink:to="loc_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment_088ea5cd-802a-4058-91bf-71dc46a6a68f" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_bf7bfa52-3e20-4157-97ef-d225984c0a04" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c5da1caa-2b81-4d33-afa5-72d11a0c71b3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_bf7bfa52-3e20-4157-97ef-d225984c0a04" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c5da1caa-2b81-4d33-afa5-72d11a0c71b3" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_401860c2-b8e2-4ab1-82c7-395508bde163" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_bf7bfa52-3e20-4157-97ef-d225984c0a04" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_401860c2-b8e2-4ab1-82c7-395508bde163" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f02f1447-c7c4-41ad-b110-3385b708b344" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
<link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_bf7bfa52-3e20-4157-97ef-d225984c0a04" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f02f1447-c7c4-41ad-b110-3385b708b344" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3d81a9a6-d39f-46ba-9f81-9aa5d691ab74" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_013bd32f-2a0f-47ec-8a97-6ef08118990a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3d81a9a6-d39f-46ba-9f81-9aa5d691ab74" xlink:to="loc_us-gaap_NetIncomeLoss_013bd32f-2a0f-47ec-8a97-6ef08118990a" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_bcbac344-f726-4b5d-8713-e3c1ecb55c94" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3d81a9a6-d39f-46ba-9f81-9aa5d691ab74" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_bcbac344-f726-4b5d-8713-e3c1ecb55c94" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_6102268c-8300-4d1a-9b89-f2cf7cde1053" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
<link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3d81a9a6-d39f-46ba-9f81-9aa5d691ab74" xlink:to="loc_us-gaap_ShareBasedCompensation_6102268c-8300-4d1a-9b89-f2cf7cde1053" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_exel_NoncashLeaseExpense_cdbb2483-64e1-4f82-8844-fd0f4c1f2632" xlink:href="exel-20230929.xsd#exel_NoncashLeaseExpense"/>
<link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3d81a9a6-d39f-46ba-9f81-9aa5d691ab74" xlink:to="loc_exel_NoncashLeaseExpense_cdbb2483-64e1-4f82-8844-fd0f4c1f2632" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_da35b059-d661-4dcf-935e-f16e6c93854d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNoncashIncomeExpense"/>
<link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3d81a9a6-d39f-46ba-9f81-9aa5d691ab74" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_da35b059-d661-4dcf-935e-f16e6c93854d" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_819ae534-59c5-4157-9654-3e321e82a582" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
<link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3d81a9a6-d39f-46ba-9f81-9aa5d691ab74" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_819ae534-59c5-4157-9654-3e321e82a582" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_91b3833e-3805-4d78-a619-fa3ea75104fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories"/>
<link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3d81a9a6-d39f-46ba-9f81-9aa5d691ab74" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_91b3833e-3805-4d78-a619-fa3ea75104fe" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_b8975ee8-318e-498c-b9a4-798f86dc7399" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
<link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3d81a9a6-d39f-46ba-9f81-9aa5d691ab74" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_b8975ee8-318e-498c-b9a4-798f86dc7399" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_367ef429-56f5-4893-b24f-c67ddc5507f9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
<link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3d81a9a6-d39f-46ba-9f81-9aa5d691ab74" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_367ef429-56f5-4893-b24f-c67ddc5507f9" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_exel_IncreaseDecreaseInAccruedCollaborationLiabilities_23df46f3-aa60-4b7f-94af-92d37c746429" xlink:href="exel-20230929.xsd#exel_IncreaseDecreaseInAccruedCollaborationLiabilities"/>
<link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3d81a9a6-d39f-46ba-9f81-9aa5d691ab74" xlink:to="loc_exel_IncreaseDecreaseInAccruedCollaborationLiabilities_23df46f3-aa60-4b7f-94af-92d37c746429" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_36b2d140-393f-4b94-86e5-1fae88859291" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff"/>
<link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3d81a9a6-d39f-46ba-9f81-9aa5d691ab74" xlink:to="loc_us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_36b2d140-393f-4b94-86e5-1fae88859291" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_34eaa073-c29a-40e1-b2d1-07131dd2a830" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_10f733d0-0297-4f0a-ab0c-34dc35d75eb8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_34eaa073-c29a-40e1-b2d1-07131dd2a830" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_10f733d0-0297-4f0a-ab0c-34dc35d75eb8" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_7d9df282-12fb-4b2f-81e1-26d5d7a6827d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
<link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_34eaa073-c29a-40e1-b2d1-07131dd2a830" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_7d9df282-12fb-4b2f-81e1-26d5d7a6827d" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_59340bdd-3a86-453f-bf3b-ce65259e8f36" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
<link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_34eaa073-c29a-40e1-b2d1-07131dd2a830" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_59340bdd-3a86-453f-bf3b-ce65259e8f36" xlink:type="arc"/>
</link:calculationLink>
<link:roleRef roleURI="http://www.exelixis.com/role/RevenuesContractAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="exel-20230929.xsd#RevenuesContractAssetsandLiabilitiesDetails"/>
<link:calculationLink xlink:role="http://www.exelixis.com/role/RevenuesContractAssetsandLiabilitiesDetails" xlink:type="extended">
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_79706232-2401-4a88-abba-c76612c3ca62" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiability"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_6055aed8-ec2e-4cc3-94f4-4cfc18e4fe36" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ContractWithCustomerLiability_79706232-2401-4a88-abba-c76612c3ca62" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_6055aed8-ec2e-4cc3-94f4-4cfc18e4fe36" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_58580bbd-fe90-4a98-a01d-ae188e1f8e92" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ContractWithCustomerLiability_79706232-2401-4a88-abba-c76612c3ca62" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_58580bbd-fe90-4a98-a01d-ae188e1f8e92" xlink:type="arc"/>
</link:calculationLink>
<link:roleRef roleURI="http://www.exelixis.com/role/CashandInvestmentsInvestmentsbySecurityTypeDetails" xlink:type="simple" xlink:href="exel-20230929.xsd#CashandInvestmentsInvestmentsbySecurityTypeDetails"/>
<link:calculationLink xlink:role="http://www.exelixis.com/role/CashandInvestmentsInvestmentsbySecurityTypeDetails" xlink:type="extended">
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_69ab2c2d-78c6-455c-9494-76e8b3e8acdc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_bb4be8fe-1d76-4e25-9478-9ec23ee6161a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_69ab2c2d-78c6-455c-9494-76e8b3e8acdc" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_bb4be8fe-1d76-4e25-9478-9ec23ee6161a" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_55f6b8e8-e694-4aff-9f26-35717bf2bf3b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_69ab2c2d-78c6-455c-9494-76e8b3e8acdc" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_55f6b8e8-e694-4aff-9f26-35717bf2bf3b" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_77ef3664-7b8b-4219-b5b6-506adcd4fc56" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
<link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_69ab2c2d-78c6-455c-9494-76e8b3e8acdc" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_77ef3664-7b8b-4219-b5b6-506adcd4fc56" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_exel_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_af20367d-856b-4857-b098-1f15cb8e4900" xlink:href="exel-20230929.xsd#exel_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
<link:loc xlink:type="locator" xlink:label="loc_exel_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsGrossUnrealizedLoss_6f6ce7d5-16e2-41a2-82d8-6ef7482df00a" xlink:href="exel-20230929.xsd#exel_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsGrossUnrealizedLoss"/>
<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_exel_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_af20367d-856b-4857-b098-1f15cb8e4900" xlink:to="loc_exel_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsGrossUnrealizedLoss_6f6ce7d5-16e2-41a2-82d8-6ef7482df00a" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_d6aaad6a-17fd-4cc6-87df-f92ebbb99b39" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_exel_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_af20367d-856b-4857-b098-1f15cb8e4900" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_d6aaad6a-17fd-4cc6-87df-f92ebbb99b39" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_exel_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCostBasis_4dc45f17-d7bf-4a93-98a2-71e2a91a0f89" xlink:href="exel-20230929.xsd#exel_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
<link:loc xlink:type="locator" xlink:label="loc_exel_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndAvailableForSaleDebtSecurities_845d9087-95ef-43a1-990f-d3ab1bd16f34" xlink:href="exel-20230929.xsd#exel_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndAvailableForSaleDebtSecurities"/>
<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_exel_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCostBasis_4dc45f17-d7bf-4a93-98a2-71e2a91a0f89" xlink:to="loc_exel_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndAvailableForSaleDebtSecurities_845d9087-95ef-43a1-990f-d3ab1bd16f34" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_exel_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_22bfd118-8766-42b7-87f9-aac0d570726c" xlink:href="exel-20230929.xsd#exel_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_exel_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCostBasis_4dc45f17-d7bf-4a93-98a2-71e2a91a0f89" xlink:to="loc_exel_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_22bfd118-8766-42b7-87f9-aac0d570726c" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_exel_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_dd4b13cb-228c-4ddb-959e-31886cde7460" xlink:href="exel-20230929.xsd#exel_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
<link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_exel_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCostBasis_4dc45f17-d7bf-4a93-98a2-71e2a91a0f89" xlink:to="loc_exel_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_dd4b13cb-228c-4ddb-959e-31886cde7460" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_exel_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_00d8024f-2141-4b78-8540-df4c471f4dce" xlink:href="exel-20230929.xsd#exel_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
<link:loc xlink:type="locator" xlink:label="loc_exel_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsGrossUnrealizedGain_fc9c8c3d-d127-4993-88f3-b101bade881e" xlink:href="exel-20230929.xsd#exel_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsGrossUnrealizedGain"/>
<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_exel_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_00d8024f-2141-4b78-8540-df4c471f4dce" xlink:to="loc_exel_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsGrossUnrealizedGain_fc9c8c3d-d127-4993-88f3-b101bade881e" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_d29c3827-d65f-49fb-b28e-7ecc6e16e5f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_exel_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_00d8024f-2141-4b78-8540-df4c471f4dce" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_d29c3827-d65f-49fb-b28e-7ecc6e16e5f6" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_exel_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndAvailableForSaleDebtSecurities_d9edafcd-8bf2-439e-8b5d-9dcf3588e994" xlink:href="exel-20230929.xsd#exel_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndAvailableForSaleDebtSecurities"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_b8186ede-9b5b-48f8-b5c0-4257b423cb22" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_exel_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndAvailableForSaleDebtSecurities_d9edafcd-8bf2-439e-8b5d-9dcf3588e994" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_b8186ede-9b5b-48f8-b5c0-4257b423cb22" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_exel_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsFairValueDisclosure_efb0d89f-18bc-4218-9c5f-b6c51e11d559" xlink:href="exel-20230929.xsd#exel_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsFairValueDisclosure"/>
<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_exel_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndAvailableForSaleDebtSecurities_d9edafcd-8bf2-439e-8b5d-9dcf3588e994" xlink:to="loc_exel_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsFairValueDisclosure_efb0d89f-18bc-4218-9c5f-b6c51e11d559" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_exel_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAmortizedCost_b74ca9e6-dbe7-4e01-8620-94a4ca07d5e6" xlink:href="exel-20230929.xsd#exel_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAmortizedCost"/>
<link:loc xlink:type="locator" xlink:label="loc_exel_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsGrossUnrealizedGain_802cdb6d-1e01-49c4-8acb-ff744442e07f" xlink:href="exel-20230929.xsd#exel_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsGrossUnrealizedGain"/>
<link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_exel_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAmortizedCost_b74ca9e6-dbe7-4e01-8620-94a4ca07d5e6" xlink:to="loc_exel_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsGrossUnrealizedGain_802cdb6d-1e01-49c4-8acb-ff744442e07f" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_exel_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsFairValueDisclosure_e4789b30-956c-4a39-8cca-8620e21cb14e" xlink:href="exel-20230929.xsd#exel_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsFairValueDisclosure"/>
<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_exel_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAmortizedCost_b74ca9e6-dbe7-4e01-8620-94a4ca07d5e6" xlink:to="loc_exel_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsFairValueDisclosure_e4789b30-956c-4a39-8cca-8620e21cb14e" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_exel_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsGrossUnrealizedLoss_94cd4433-ecdb-4c73-9f6b-d84897c50c30" xlink:href="exel-20230929.xsd#exel_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsGrossUnrealizedLoss"/>
<link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_exel_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAmortizedCost_b74ca9e6-dbe7-4e01-8620-94a4ca07d5e6" xlink:to="loc_exel_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsGrossUnrealizedLoss_94cd4433-ecdb-4c73-9f6b-d84897c50c30" xlink:type="arc"/>
</link:calculationLink>
<link:roleRef roleURI="http://www.exelixis.com/role/CashandInvestmentsInvestmentsbySecurityTypeDetails_1" xlink:type="simple" xlink:href="exel-20230929.xsd#CashandInvestmentsInvestmentsbySecurityTypeDetails_1"/>
<link:calculationLink xlink:role="http://www.exelixis.com/role/CashandInvestmentsInvestmentsbySecurityTypeDetails_1" xlink:type="extended">
<link:loc xlink:type="locator" xlink:label="loc_exel_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCostBasis_4b026200-8201-4b6a-9bbe-19a925b37686" xlink:href="exel-20230929.xsd#exel_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
<link:loc xlink:type="locator" xlink:label="loc_exel_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAmortizedCost_f38e4b5d-380d-496c-8cd4-1029e57048bb" xlink:href="exel-20230929.xsd#exel_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAmortizedCost"/>
<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_exel_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCostBasis_4b026200-8201-4b6a-9bbe-19a925b37686" xlink:to="loc_exel_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAmortizedCost_f38e4b5d-380d-496c-8cd4-1029e57048bb" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_9e53fedf-20ca-4900-9fd6-0be67ea1d364" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_exel_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCostBasis_4b026200-8201-4b6a-9bbe-19a925b37686" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_9e53fedf-20ca-4900-9fd6-0be67ea1d364" xlink:type="arc"/>
</link:calculationLink>
<link:roleRef roleURI="http://www.exelixis.com/role/CashandInvestmentsFairValueofCashEquivalentsandInvestmentsbyContractualMaturityDetails" xlink:type="simple" xlink:href="exel-20230929.xsd#CashandInvestmentsFairValueofCashEquivalentsandInvestmentsbyContractualMaturityDetails"/>
<link:calculationLink xlink:role="http://www.exelixis.com/role/CashandInvestmentsFairValueofCashEquivalentsandInvestmentsbyContractualMaturityDetails" xlink:type="extended">
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_9807409d-5648-47df-ac32-fb46a2e6cb20" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_1ba322aa-fba6-48bc-8852-04ce8d34ef8b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_9807409d-5648-47df-ac32-fb46a2e6cb20" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_1ba322aa-fba6-48bc-8852-04ce8d34ef8b" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_fb18b219-f88a-4099-a9fb-326483a0e01f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_9807409d-5648-47df-ac32-fb46a2e6cb20" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_fb18b219-f88a-4099-a9fb-326483a0e01f" xlink:type="arc"/>
</link:calculationLink>
<link:roleRef roleURI="http://www.exelixis.com/role/FairValueMeasurementsFairValueHierarchyDetails" xlink:type="simple" xlink:href="exel-20230929.xsd#FairValueMeasurementsFairValueHierarchyDetails"/>
<link:calculationLink xlink:role="http://www.exelixis.com/role/FairValueMeasurementsFairValueHierarchyDetails" xlink:type="extended">
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_149582ab-ee8a-46cd-b14f-0896bd1d483c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_a5901730-b890-4adf-80c1-c1252a30c874" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_149582ab-ee8a-46cd-b14f-0896bd1d483c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_a5901730-b890-4adf-80c1-c1252a30c874" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_f7c9e5a2-39c7-45ec-8c8d-0964044738a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_149582ab-ee8a-46cd-b14f-0896bd1d483c" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_f7c9e5a2-39c7-45ec-8c8d-0964044738a3" xlink:type="arc"/>
</link:calculationLink>
<link:roleRef roleURI="http://www.exelixis.com/role/InventoryDetails" xlink:type="simple" xlink:href="exel-20230929.xsd#InventoryDetails"/>
<link:calculationLink xlink:role="http://www.exelixis.com/role/InventoryDetails" xlink:type="extended">
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryGross_6b64d6bd-ef7e-4080-8f5c-7c938123e63d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryGross"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterials_2c3d062d-5c23-4b3a-9317-c7bc42a1115c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryRawMaterials"/>
<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryGross_6b64d6bd-ef7e-4080-8f5c-7c938123e63d" xlink:to="loc_us-gaap_InventoryRawMaterials_2c3d062d-5c23-4b3a-9317-c7bc42a1115c" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcess_cc865eb5-5b19-4a86-9467-36a37a8c92ba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryWorkInProcess"/>
<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryGross_6b64d6bd-ef7e-4080-8f5c-7c938123e63d" xlink:to="loc_us-gaap_InventoryWorkInProcess_cc865eb5-5b19-4a86-9467-36a37a8c92ba" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods_8334b310-421c-42c0-9d70-9408510158be" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoods"/>
<link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryGross_6b64d6bd-ef7e-4080-8f5c-7c938123e63d" xlink:to="loc_us-gaap_InventoryFinishedGoods_8334b310-421c-42c0-9d70-9408510158be" xlink:type="arc"/>
</link:calculationLink>
<link:roleRef roleURI="http://www.exelixis.com/role/NetIncomePerShareComputationofBasicandDilutedNetIncomePerShareDetails" xlink:type="simple" xlink:href="exel-20230929.xsd#NetIncomePerShareComputationofBasicandDilutedNetIncomePerShareDetails"/>
<link:calculationLink xlink:role="http://www.exelixis.com/role/NetIncomePerShareComputationofBasicandDilutedNetIncomePerShareDetails" xlink:type="extended">
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_056efbcb-0c5b-441f-a34e-b4deb48a3ba1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_ce995a4d-904b-4c61-9f6d-82ceecaf0f43" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_056efbcb-0c5b-441f-a34e-b4deb48a3ba1" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_ce995a4d-904b-4c61-9f6d-82ceecaf0f43" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_3a712bb1-600f-43b5-9721-e4a44ae16163" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_056efbcb-0c5b-441f-a34e-b4deb48a3ba1" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_3a712bb1-600f-43b5-9721-e4a44ae16163" xlink:type="arc"/>
</link:calculationLink>
</link:linkbase>


1 Subsequent Filing that References this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/06/24  Exelixis, Inc.                    10-K       12/29/23   95:11M


2 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/05/21  Exelixis, Inc.                    10-Q        7/02/21   71:7.7M
 3/03/21  Exelixis, Inc.                    8-K:3,5,9   2/25/21   13:651K
Top
Filing Submission 0000939767-23-000114   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sun., May 12, 9:53:24.1am ET